Resource Use and Health Care Costs of COPD Patients at the End of Life: A Systematic Review

Journal of Pain and Symptom Management

Volumn 52, Issue 4, 2016, Pages 588-599

  Faes, Kristof ^a   De Frène, Veerle ^a   Cohen, Joachim ^b   Annemans, Lieven ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

chronic obstructive pulmonary disease; COPD; costs; End of life; resource use; systematic review

Indexed keywords

CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSULTATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL UTILIZATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LUNG CANCER; PALLIATIVE THERAPY; PRESCRIPTION; PRIMARY MEDICAL CARE; REVIEW; SYSTEMATIC REVIEW; TERMINAL CARE; ECONOMICS; PATIENT ATTITUDE; UTILIZATION;

HEALTH CARE COSTS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TERMINAL CARE;

EID: 84994480574     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2016.04.007     Document Type: Review

References (35)

1. 1 Halbert, R.J., Natoli, J.L., Gano, A., et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28 (2006), 523–532.
2. 2 Sin, D.D., Anthonisen, N.R., Soriano, J.B., Agusti, A.G., Mortality in COPD: role of comorbidities. Eur Respir J 28 (2006), 1245–1257.
3. 3 World Health Organization. Chronic obstructive pulmonary disease (COPD). Fact sheet N°315. 2015 Available at: http://www.who.int/mediacentre/factsheets/fs315/en/ Accessed February 27, 2015.
4. 4 World Health Organization. Chronic respiratory diseases. Chronic obstructive pulmonary disease (COPD). 2015 Available at: http://www.who.int/respiratory/copd/en/ Accessed February 27, 2015.
5. 5 European COPD Coalition. COPD: prevalence in EU. 2015 Available at: http://www.copdcoalition.eu/about-copd/prevalence Accessed February 27, 2015.
6. 6 Yang, H., Xiang, P., Zhang, E., et al. Predictors of exacerbation frequency in chronic obstructive pulmonary disease. Eur J Med Res, 19, 2014, 18.
7. 7 Hansen-Flaschen, J., Chronic obstructive pulmonary disease: the last year of life. Respir Care 49 (2004), 90–97 discussion 97–8.
8. 8 Smith, M.C., Wrobel, J.P., Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chronic Obstr Pulm Dis 9 (2014), 871–888.
9. 9 Anzueto, A., Impact of exacerbations on COPD. Eur Respir Rev 19 (2010), 113–118.
10. 10 Mannino, D.M., Higuchi, K., Yu, T.C., et al. Economic burden of chronic obstructive pulmonary disease by presence of comorbidities. Chest 148 (2015), 138–150.
11. 11 Jansson, S.A., Andersson, F., Borg, S., et al. Costs of COPD in Sweden according to disease severity. Chest 122 (2002), 1994–2002.
12. 12 Goodridge, D., People with chronic obstructive pulmonary disease at the end of life: a review of the literature. Int J Palliat Nurs 12 (2006), 390–396.
13. 13 Mannino, D.M., Doherty, D.E., Sonia Buist, A., Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 100 (2006), 115–122.
14. 14 Seemungal, T.A., Hurst, J.R., Wedzicha, J.A., Exacerbation rate, health status and mortality in COPD–a review of potential interventions. Int J Chron Obstruct Pulmon Dis 4 (2009), 203–223.
15. 15 Motheral, B., Brooks, J., Clark, M.A., et al. A checklist for retrospective database studies–report of the ISPOR Task Force on Retrospective Databases. Value Health 6 (2003), 90–97.
16. 16 Lau, K.S., Tse, D.M., Chen, T.W.T., et al. Comparing noncancer and cancer deaths in Hong Kong. A retrospective review. J Pain Symptom Manage 40 (2010), 704–714.
17. 17 Andersson, F.L., Svensson, K., de Verdier, M.G., Hospital use for COPD patients during the last few years of their life. Respir Med 100 (2006), 1436–1441.
18. 18 Goodridge, D., Lawson, J., Duggleby, W., et al. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med 102 (2008), 885–891.
19. 19 Goodridge, D., Lawson, J., Rennie, D., Marciniuk, D., Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life. Rural Remote Health, 10, 2010, 1349.
20. 20 Teno, J.M., Gozalo, P.L., Bynum, J.P., et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA 309 (2013), 470–477.
21. 21 Au, D.H., Udris, E.M., Fihn, S.D., McDonell, M.B., Curtis, J.R., Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 166 (2006), 326–331.
22. 22 Chou, W.C., Lai, Y.T., Hung, Y.S., Comparing end-of-life care in hospitalized patients with chronic obstructive pulmonary disease with and without palliative care in Taiwan. J Res Med Sci 18 (2013), 594–600.
23. 23 Fahlman, C., Lynn, J., Doberman, D., Gabel, J., Finch, M., Prescription drug spending for Medicare+Choice beneficiaries in the last year of life. J Palliat Med 9 (2006), 884–893.
24. 24 Husted, M.G., Kriegbaum, M., Kirkegaard, N., Lange, P., The use of healthcare resources in the last 3 years of life in patients with COPD and lung cancer in Denmark. A retrospective nationwide study. BMJ Support Palliat Care 4 (2014), 146–151.
25. 25 Vitacca, M., Grassi, M., Barbano, L., et al. Last 3 months of life in home-ventilated patients: the family perception. Eur Respir J 35 (2010), 1064–1071.
26. 26 Claessens, M.T., Lynn, J., Zhong, Z., et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc 48 (2000), S146–S153.
27. 27 Gore, J.M., Brophy, C.J., Greenstone, M.A., How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 55 (2000), 1000–1006.
28. 28 Tranmer, J.E., Heyland, D., Dudgeon, D., et al. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage 25 (2003), 420–429.
29. 29 Solano, J.P., Gomes, B., Higginson, I.J., A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 31 (2006), 58–69.
30. 30 Habraken, J.M., ter Riet, G., Gore, J.M., et al. Health-related quality of life in end-stage COPD and lung cancer patients. J Pain Symptom Manage 37 (2009), 973–981.
31. 31 Curtis, J.R., Palliative and end-of-life care for patients with severe COPD. Eur Respir J 32 (2008), 796–803.
32. 32 Vermylen, J.H., Szmuilowicz, E., Kalhan, R., Palliative care in COPD: an unmet area for quality improvement. Int J Chron Obstruct Pulmon Dis 10 (2015), 1543–1551.
33. 33 Simoni-Wastila, L., Blanchette, C.M., Qian, J., et al. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Am J Geriatr Pharmacother 7 (2009), 262–270.
34. 34 Shugarman, L.R., Decker, S.L., Bercovitz, A., Demographic and social characteristics and spending at the end of life. J Pain Symptom Manage 38 (2009), 15–26.
35. 35 Earle, C.C., Ayanian, J.Z., Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol 24 (2006), 838–840.